Technical Analysis for CBPO - China Biologic Products, Inc.

Grade Last Price % Change Price Change
grade B 86.97 0.50% 0.43
CBPO closed up 0.5 percent on Monday, March 18, 2019, on 2.12 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CBPO trend table...

Date Alert Name Type % Chg
Mar 18 NR7 Range Contraction 0.00%
Mar 18 NR7-2 Range Contraction 0.00%
Mar 18 Inside Day Range Contraction 0.00%
Mar 18 Overbought Stochastic Strength 0.00%
Mar 15 NR7 Range Contraction 0.50%
Mar 15 Overbought Stochastic Strength 0.50%
Mar 14 Upper Bollinger Band Walk Strength 2.34%
Mar 14 Overbought Stochastic Strength 2.34%
Mar 13 Pocket Pivot Bullish Swing Setup 0.55%
Mar 13 Volume Surge Other 0.55%

Older signals for CBPO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

China Biologic Products, Inc., a biopharmaceutical company, through its subsidiaries, engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human albumin and human immunoglobulin for intravenous injection (IVIG) products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides injection that is used for the treatment of various original and secondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseases, as well as assists in the treatment for tumors. In addition, it provides human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; human tetanus immunoglobulin for the prevention and therapy of tetanus; and placenta polypeptide that is used for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia caused by various reasons, as well as assists in postoperative heating. The company's products under development comprise human prothrombin complex concentrate; human hepatitis B immunoglobulin (PH4) for intravenous injection; human fibrinogen; Varicella hyperimmune globulins; and Human IVIG. It distributes its products directly or through distributors. The company is based in Beijing, the People's Republic of China.
Medicine Biopharmaceutical Immunology Antibodies Immune System Tumors Glycoproteins Rabies Hydrocephalus Immunoglobulin Therapy Measles Shock Tetanus Varicella
Is CBPO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 107.44
52 Week Low 60.08
Average Volume 165,051
200-Day Moving Average 83.5523
50-Day Moving Average 80.965
20-Day Moving Average 82.9545
10-Day Moving Average 85.205
Average True Range 2.7309
ADX 17.94
+DI 19.3754
-DI 11.5617
Chandelier Exit (Long, 3 ATRs ) 79.23730000000001
Chandelier Exit (Short, 3 ATRs ) 87.2527
Upper Bollinger Band 87.9525
Lower Bollinger Band 77.9565
Percent B (%b) 0.9
BandWidth 12.049979
MACD Line 1.7471
MACD Signal Line 1.3837
MACD Histogram 0.3634
Fundamentals Value
Market Cap 2.37 Billion
Num Shares 27.2 Million
EPS 3.84
Price-to-Earnings (P/E) Ratio 22.65
Price-to-Sales 6.40
Price-to-Book 4.00
PEG Ratio 1.53
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 90.17
Resistance 3 (R3) 89.90 88.56 89.63
Resistance 2 (R2) 88.56 87.75 88.70 89.45
Resistance 1 (R1) 87.77 87.25 88.17 88.04 89.28
Pivot Point 86.43 86.43 86.63 86.57 86.43
Support 1 (S1) 85.64 85.62 86.04 85.91 84.66
Support 2 (S2) 84.30 85.12 84.44 84.49
Support 3 (S3) 83.51 84.30 84.31
Support 4 (S4) 83.78